| abstract |
PROBLEM TO BE SOLVED: To provide a pharmaceutical composition comprising target-specific stealth-type nanoparticles having a targeting moiety in an amount effective for treating prostate cancer in a subject in need of treatment for prostate cancer. A plurality of target-specific stealth-type nanoparticles comprising therapeutic agents such as mitoxantrone and docetaxel, wherein the nanoparticles contain a targeting moiety that is bound to the nanoparticles, and the targeting moiety Wherein the pharmaceutical composition is a low molecular weight prostate specific membrane antigen (PSMA) ligand selected from the following compounds: [Selection] Figure 1 |